New Details on the Revision of USP Chapter 1
Recommendation

Thursday, 26 November 2026 9 .00 - 17.15 h
As already reported in the news "Second Revision of USP Chapter <1> Injections and Implanted Drug Products (Parenterals)-Product Quality Tests", USP's Chapter <1> "Injections and Implanted Drug Products (Parenterals)-Product Quality Tests' has been revised again. New information is now available.
The USP published these details on 25 March. The revised version now contains a table of contents for a better overview whereas the Product Performance Test at the end of the Chapter has been deleted. All details about the new version of USP's Chapter <1> can be found on the USP website.
The revised Chapter will become effective on May 1st, 2016.
Related GMP News
02.11.2026New Version of VDI Guideline 2083 Sheet 15
28.10.2026FDA Warning Letter for a microbially contaminated Sterile Solution
07.10.2026USP Revises the Pharmaceutical Water Monographs
23.09.2026FDA criticises Visual Inspection


